Get 20M+ Full-Text Papers For Less Than $1.50/day. Subscribe now for You or Your Team.

Learn More →

Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group.

Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy:... This is one of two separate clinical trials to evaluate the efficacy and safety of modafinil, a novel wake-promoting agent, in patients with excessive daytime sleepiness (EDS) associated with narcolepsy. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Neurology Pubmed

Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group.

Neurology , Volume 54 (5): -1090 – Jun 28, 2000

Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group.


Abstract

This is one of two separate clinical trials to evaluate the efficacy and safety of modafinil, a novel wake-promoting agent, in patients with excessive daytime sleepiness (EDS) associated with narcolepsy.

Loading next page...
 
/lp/pubmed/randomized-trial-of-modafinil-as-a-treatment-for-the-excessive-daytime-BWD4F3MmuJ

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0028-3878
DOI
10.1212/wnl.54.5.1166
pmid
10720292

Abstract

This is one of two separate clinical trials to evaluate the efficacy and safety of modafinil, a novel wake-promoting agent, in patients with excessive daytime sleepiness (EDS) associated with narcolepsy.

Journal

NeurologyPubmed

Published: Jun 28, 2000

There are no references for this article.